Patients News | pharmaphorum

News

Vertex's gene-editing therapy for sickle cell disease, Casgevy, has been given the nod for use by the NHS in England after an earlier rejection.

News

Recent financings in the digital health and AI space include rounds for Rad AI, Eleos, Allara Health, Manas AI, Delfina Care, and Grey Matter Neuro.

News

UK Biobank study suggests someone's risk of premature ageing or cognitive decline could be predicted using a simple ECG reading supported by an AI.

News

ALK-Abello's Acarizax for dust mite allergy should soon be available through the NHS in England, Wales and Northern Ireland, but not in Scotland.

News

Robert F Kennedy Jr's first confirmation hearing was a fractious affair, marked by tough questions about his prior anti-vaccine stance.

News

Genetic testing specialist 23andMe has launched a strategic review that could result in a sale of the company.